Europlasma advises the CEO on the co-investment with Gimv in Europlasma

In October 2014, GIMV and YUKON acquired the technology company Europlasma in order to support its ambitious growth plan. OMNICAP advised YUKON, represented by Filip LEGEIN, as management and co-investor in this transaction.

EUROPLASMA (, headquartered in Oudenaarde (Belgium), is the market leader in the development of plasma based nano-coating solutions to make liquid-repellent electronics and textiles. Manufacturers use the patented technology of EUROPLASMA for protective coatings of electronic devices (such as mobile phones, tablets and headphones), electronic components, outdoor textiles and medical instruments.

EUROPLASMA looked for additional capital to broaden its R&D efforts, to boost the production and to further develop the international outlook.

Filip LEGEIN, already active as CEO of EUROPLASMA and founder of YUKON, has led for years the intensive but successful R&D project within EUROPLASMA and he looked for a partner in order to back the ambitious international growth.

YUKON is a hands-on private equity fund, which follows actively its investments in view of creation of shareholders’ value by assuming an active role in the management.

Following on the entry of GIMV into the capital of the company, YUKON has increased its existing stake in EUROPLASMA.

Filip LEGEIN, CEO of EUROPLASMA and founder of YUKON, on the transaction:

“After more than 15 years of intensive R&D we have seen key customers in several industries implementing the technology on an industrial scale. This is the moment to bring the company to the next level and we are very happy that Gimv, as our new majority shareholder, has decided to support our ambitious growth. The new funds will be used to finance our growth, to expand our global network and to intensify our R&D-efforts. Our goals are to remain the market leader in the fast growing markets that we target and to develop new applications of our technology platform.”

← Terug naar overzicht